Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2025-12-24 @ 5:18 PM
NCT ID:
NCT05763550
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent;
* Males or females aged 18 years and older ;
* Patients must have herpetic neuralgia;
* At Screening, pain scale (VAS) of ≥ 40 mm;
* At Screening, pain scale (NRS) of ≥ 4.
Exclusion Criteria:
* Patients have pain present for more than 1 months after the healing of the herpes zoster skin rash;
* AST/ALT \> 2 × upper limit of normal (ULN), or TBIL≥1.5 × ULN;
* Serum Creatine \> 176μmol/L;
* Any active infections at screening;
* History of allergic or medically significant adverse reaction to investigational products or their excipients, pregabalin or related compounds;
* Participated in another clinical study within 30 days prior to screening;
* Pregnant or breastfeeding at screening ;
* Other conditions unlikely to participate in this trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05763550
Study Brief:
Protocol Section:
NCT05763550